holoclar
holostem s.r.l - ex vivo ekspandirane autologne humane epitelialne stanice rožnice koje sadrže matične stanice - stem cell transplantation; corneal diseases - ophthalmologicals - liječenje odraslih bolesnika s umjerenim do teškim limbal matičnih stanica nedostatak (definiran prisutnost površna rožnice neovaskularizacije u najmanje dvije rožnice kvadranta, učešćem središnje rožnice, i teško oštećena vida), jednostrana ili obostrana, zbog fizičke ili kemijske opekline oka. za biopsiju je potrebno najmanje 1-2 mm2 neoštećenog limbusa.
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - imunomodulatori za mačke, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - imunomodulatori za mačke, - mačke - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. pokusi imuniteta pokazani su tjedan dana nakon primarnog cijepljenja za rhinotracheitis, kalicivirus, chlamydophila felis i panleucopenia komponente. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunomodulatori za mačke, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
iv konektori, setovi, ventili za intravenozne sustave i valvule za enteralno hranjenje
pharmamed mado d.o.o., zagreb - iv konektori, setovi, ventili za intravenozne sustave i valvule za enteralno hranjenje
mirataz
dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - mačke - za povećanje tjelesne težine mačke, doživljava loš apetit i gubitak težine, kao rezultat kronične bolesti.
fluad tetra
seqirus netherlands b.v. - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) / a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238) / b/phuket/3073/2013-like strain (b/phuket/3073/2013, bvr-1b) / influenza virus b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - gripa, ljudska - cjepiva - prevencija gripe kod osoba starije dobi (65 godina i stariji). fluad tetra treba primjenjivati u skladu sa službenim preporukama.
exelon 1.5 mg/1 kapsula kapsula, tvrda
novartis ba d.o.o. - rivastigmin - kapsula, tvrda - 1.5 mg/1 kapsula - 1 kapsula, tvrda sadrži: 1,5 mg rivastigmina (u obliku rivastigminhidrogentartarata)
exelon 3 mg/1 kapsula kapsula, tvrda
novartis ba d.o.o. - rivastigmin - kapsula, tvrda - 3 mg/1 kapsula - 1 kapsula, tvrda sadrži: 3 mg rivastigmina (u obliku rivastigminhidrogentartarata)
corlentor
les laboratoires servier - ivabradin hidroklorid - angina pectoris; heart failure - srČani terapija - simptomatsko liječenje kronične stabilne angine pectorisivabradine indiciran za simptomatsko liječenje kronične stabilne angine pri kbs odrasla osoba s normalnim синусовым ritam i definiranju ≥ 70 уд.. Ивабрадин prikazan:u odraslih, ne uvažavaju tolerirati ili s противопоказанием za primjenu beta-blockersor u kombinaciji s beta-адреноблокаторами kod pacijenata sa adekvatno kontrolirani optimalan beta-blokator doze. liječenje kroničnog zatajenja failureivabradine prikazan kod kroničnog zatajenja srca u nyha od ii do iv klase s систолической disfunkcije kod pacijenata s синусовым ritam i čija definiranju ≥ 75 otkucaja / min, u kombinaciji sa standardnom terapijom, uključujući beta-blokatori ili kada su beta-blokatori kontraindiciran ili ne migriraju.